120 related articles for article (PubMed ID: 2883778)
1. [Eicosanoids in chronic inflammatory intestinal diseases].
Müller G
Z Gesamte Inn Med; 1987 Jan; 42(2):37-41. PubMed ID: 2883778
[TBL] [Abstract][Full Text] [Related]
2. Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
Lauritsen K
Dan Med Bull; 1989 Sep; 36(4):378-93. PubMed ID: 2572403
[No Abstract] [Full Text] [Related]
3. [The role of arachidonic acid metabolism in the pathophysiology of chronic inflammatory intestinal diseases].
Schreiber S; Raedler A
Immun Infekt; 1990 Aug; 18(4):115-20. PubMed ID: 2210793
[TBL] [Abstract][Full Text] [Related]
4. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.
Sharon P; Stenson WF
Gastroenterology; 1984 Mar; 86(3):453-60. PubMed ID: 6319219
[TBL] [Abstract][Full Text] [Related]
5. [The role of cytokines in the pathogenesis of inflammatory intestinal diseases].
Hommes DW; van Dullemen H; Radema SA; Tytgat GN; van Deventer SJ
Ned Tijdschr Geneeskd; 1994 Dec; 138(49):2427-32. PubMed ID: 7997297
[No Abstract] [Full Text] [Related]
6. [Significance of free oxygen radicals for pathogenesis of chronic inflammatory disease].
Nielsen OH; Ahnfelt-Rønne I
Ugeskr Laeger; 1992 Sep; 154(38):2544-6. PubMed ID: 1357806
[No Abstract] [Full Text] [Related]
7. Prostaglandins and ulcerative colitis, a warning.
Gerber JG
Gastroenterology; 1979 Mar; 76(3):658. PubMed ID: 34557
[No Abstract] [Full Text] [Related]
8. [Immunohistochemical study of HLA-DR expression in superficial epithelium and in lamina propria of colonic mucosa in children with Crohn's disease and nonspecific ulcerative colitis].
Rodrigues M; Zerbini MC; Barbieri D
Arq Gastroenterol; 1998; 35(2):143-51. PubMed ID: 9814381
[TBL] [Abstract][Full Text] [Related]
9. [Mode of action of sulfasalazine in chronic inflammatory enterocolonic diseases].
Delboy H
Therapie; 1992; 47(2):157-9. PubMed ID: 1357770
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
11. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
Schölmerich J
Praxis (Bern 1994); 1995 Jan; 84(2):29-33. PubMed ID: 7839043
[TBL] [Abstract][Full Text] [Related]
12. Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway.
Donowitz M
Gastroenterology; 1985 Feb; 88(2):580-7. PubMed ID: 2856909
[No Abstract] [Full Text] [Related]
13. [Drug treatment of chronic inflammatory intestinal diseases with special reference to 5-azosalicylic acid].
Fahrländer H
Schweiz Med Wochenschr; 1987 Oct; 117(42):1620-3. PubMed ID: 3321418
[TBL] [Abstract][Full Text] [Related]
14. In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis.
Lauritsen K; Laursen LS; Bukhave K; Rask-Madsen J
Gastroenterology; 1988 Jul; 95(1):11-7. PubMed ID: 2836256
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics of Azulfidine/Salazopyrin in healthy humans and in patients with chronic inflammatory bowel diseases].
Van Hees PA
Z Gastroenterol Verh; 1981 Jun; 19():7-14. PubMed ID: 6168136
[No Abstract] [Full Text] [Related]
16. [Drug treatment of chronic inflammatory diseases of the intestine].
Modigliani R
Schweiz Med Wochenschr; 1988 May; 118(20):737. PubMed ID: 2898809
[No Abstract] [Full Text] [Related]
17. [Arachidonic acid metabolism in inflammatory bowel disease--with reference to cyclooxygenase products].
Yamazaki H; Hiwatashi N; Goto Y
Nihon Shokakibyo Gakkai Zasshi; 1985 Oct; 82(10):2562-8. PubMed ID: 3936952
[No Abstract] [Full Text] [Related]
18. Mechanisms of diarrhea in inflammatory bowel diseases.
Binder HJ
Ann N Y Acad Sci; 2009 May; 1165():285-93. PubMed ID: 19538318
[TBL] [Abstract][Full Text] [Related]
19. [Possible mechanism of action of Azulfidine/Salazopyrin].
Campbell DE
Z Gastroenterol Verh; 1981 Jun; 19():15-20. PubMed ID: 6168126
[No Abstract] [Full Text] [Related]
20. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
